APP and Alzheimer disease: It is well known that under the physiological condition, APP undergoes nontoxic cleavage by the α-secretase ADAM10 (a disintegrin and metalloprotease), while in the pathological situation of AD, β-secretase mediated cleavage to generate Aβ peptides is increased.